A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

A total of 24 subjects will be randomized into 6 sequence groups. The Investigational Products wil be according to the treatment group (A,B,C) assigned to each sequence group in Period 1, Period 2 and Period 3.

A Randomized, Open-label, Three-treatment, Six-sequence, Three-period, Crossover Clinical Study to Compare the Pharmacokinetic Characteristics Between Twice Daily Administration of BR9003A and Once Daily Administration of BR9003 in Healthy Adult Subjects

The purpose of this study is to evaluate the pharmacokinetics and safety of oral administration of BR9003 compared with BR9003A in healthy adult subjects

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Recruitment

Summary

Participation Requirements

Description

Tracking Information